Total Payments
$7,518
2024 Payments
$605.69
Companies
46
Transactions
558
Medicare Patients
1,474
Medicare Billing
$153,352
Payment Breakdown by Category
Food & Beverage$7,377 (98.1%)
Education$141.11 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,377 | 547 | 98.1% |
| Education | $141.11 | 11 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $929.47 | 59 | $0 (2024) |
| ABBVIE INC. | $832.41 | 69 | $0 (2024) |
| Lilly USA, LLC | $733.49 | 57 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $674.58 | 44 | $0 (2024) |
| Novo Nordisk Inc | $573.62 | 63 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $432.31 | 27 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $347.79 | 25 | $0 (2021) |
| Allergan, Inc. | $305.98 | 29 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $304.16 | 24 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $299.90 | 27 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $605.69 | 38 | ABBVIE INC. ($279.87) |
| 2023 | $591.36 | 41 | Lilly USA, LLC ($187.75) |
| 2022 | $995.73 | 63 | AstraZeneca Pharmaceuticals LP ($185.59) |
| 2021 | $1,105 | 90 | AbbVie Inc. ($275.50) |
| 2020 | $1,001 | 77 | Allergan, Inc. ($181.85) |
| 2019 | $832.95 | 66 | Janssen Pharmaceuticals, Inc ($133.16) |
| 2018 | $1,241 | 93 | Boehringer Ingelheim Pharmaceuticals, Inc. ($148.72) |
| 2017 | $1,145 | 90 | AstraZeneca Pharmaceuticals LP ($148.59) |
All Payment Transactions
558 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.01 | General |
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 09/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Oncology | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: DIABETES | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/20/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Obesity | ||||||
| 06/18/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 06/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 283 | 526 | $75,724 | $27,713 |
| 2022 | 10 | 388 | 751 | $122,892 | $42,521 |
| 2021 | 11 | 387 | 765 | $123,163 | $45,929 |
| 2020 | 9 | 416 | 785 | $105,852 | $37,189 |
Total Patients
1,474
Total Services
2,827
Medicare Billing
$153,352
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 194 | $33,756 | $11,508 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 121 | $30,008 | $7,281 | 24.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $6,716 | $5,603 | 83.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 39 | 76 | $2,280 | $997.12 | 43.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $1,040 | $935.09 | 89.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $832.00 | $752.18 | 90.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 37 | $702.00 | $352.24 | 50.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $390.00 | $284.70 | 73.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 293 | $72,664 | $22,017 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $9,490 | $8,090 | 85.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 127 | $22,098 | $6,935 | 31.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 54 | 104 | $3,120 | $1,376 | 44.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 13 | $11,895 | $1,154 | 9.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $996.00 | $972.36 | 97.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 23 | 23 | $736.00 | $689.31 | 93.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $703.00 | $688.94 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 29 | 55 | $990.00 | $519.09 | 52.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 12 | 20 | $200.00 | $79.28 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 270 | $62,012 | $21,935 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 66 | 66 | $9,900 | $8,371 | 84.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 80 | $13,880 | $4,370 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 79 | $12,694 | $4,146 | 32.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 15 | 15 | $12,450 | $1,490 | 12.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 14 | $4,536 | $1,389 | 30.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 51 | 100 | $3,530 | $1,339 | 37.9% |
About Dr. Kirtida Ringwala, MD
Dr. Kirtida Ringwala, MD is a Internal Medicine healthcare provider based in Oshkosh, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356376966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kirtida Ringwala, MD has received a total of $7,518 in payments from pharmaceutical and medical device companies, with $605.69 received in 2024. These payments were reported across 558 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,377).
As a Medicare-enrolled provider, Ringwala has provided services to 1,474 Medicare beneficiaries, totaling 2,827 services with total Medicare billing of $153,352. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Oshkosh, WI
- Active Since 07/12/2006
- Last Updated 11/17/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356376966
Products in Payments
- VRAYLAR (Drug) $586.55
- FARXIGA (Drug) $433.71
- TRULICITY (Drug) $359.02
- STIOLTO RESPIMAT (Drug) $322.59
- BREZTRI (Drug) $278.29
- JANUVIA (Drug) $263.89
- VYVANSE (Drug) $214.70
- JARDIANCE (Drug) $198.28
- EMGALITY (Drug) $187.82
- Ozempic (Drug) $172.29
- XARELTO (Drug) $171.94
- UBRELVY (Drug) $170.40
- TOUJEO (Drug) $149.14
- SOLIQUA (Drug) $148.60
- LINZESS (Drug) $146.53
- ENTRESTO (Drug) $141.46
- TRINTELLIX (Drug) $140.41
- Trintellix (Drug) $130.98
- INVOKANA (Drug) $127.96
- Tresiba (Drug) $123.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oshkosh
Dr. Amir Butt, M.d, M.D
Internal Medicine — Payments: $2,867
Internal Medicine $2,867
Isna Khan
Internal Medicine — Payments: $1,138
Internal Medicine $1,138
Ioannis Karkatzounis, Md, MD
Internal Medicine — Payments: $593.38
Internal Medicine $593.38
Dr. John Steiner, Md, MD
Internal Medicine — Payments: $522.32
Internal Medicine $522.32
Awais Ahmed, Md, MD
Internal Medicine — Payments: $320.80
Internal Medicine $320.80
Christopher Westra, Md, MD
Internal Medicine — Payments: $256.14
Internal Medicine $256.14